Company Overview of Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization is based in the United States.
177 North State Street
Chicago, IL 60601
Key Executives for Illinois Biotechnology Industry Organization
Chief Executive Officer and President
Vice Chairman of Human Health
Vice Chairman of Food & Agriculture and Director
Vice Chairman for Food & Agriculture and Director
Compensation as of Fiscal Year 2016.
Illinois Biotechnology Industry Organization Key Developments
Illinois Biotechnology Industry Organization Announces Board Changes
Dec 16 15
Timothy P Walbert has been elected as chairman of the Illinois Biotechnology Industry Organization Board of Directors. He succeeds Andrew Hull, Takeda Pharmaceutical, who served as chairman for the past two years and will continue to serve on the Board and Executive Committee as Immediate Past Chairman. Walbert is the Chairman, President and Chief Executive Officer of Horizon Pharma plc.
The Illinois Biotechnology Industry Organization Announces Board Changes
Jul 27 15
The Illinois Biotechnology Industry Organization announced the election of new additions to its board of directors. Joining the company’s board are Walt Johnston and David Flowers. Walt Johnston is Vice President, US Marketing and Strategic New Product Planning for Astellas Pharma US Inc. Walt has over 20 years of experience in the pharmaceutical industry. David Flowers is a Director, Life Sciences Industry, for Deloitte Services LP.
Illinois Biotechnology Industry Organization and iBIO Institute Appoint Warren Ribley as President & CEO
Jan 6 15
The Illinois Biotechnology Industry Organization and its affiliate, the iBIO Institute announced that Warren Ribley has been named President & CEO of both organizations. He will assume his new responsibilities at the beginning of February 2015. Appointed to lead the Illinois Medical District in April of 2012, Ribley is widely credited with revitalizing the District and attracting new tenants and life sciences developments, including the University of Illinois’ Health Technology Innovation center (HTI). Ribley succeeds outgoing iBIO and iBIO Institute President & CEO, David Miller, who has led the iBIO organizations for over twelve years and last year announced his plans to retire in early 2015.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries